Abstract
Objective: To analyze the main neuroinflammatory mechanisms involved in the pathophysiology of Post-Traumatic Stress Disorder (PTSD) and their clinical implications. Literature review: Post-Traumatic Stress Disorder is a chronic psychiatric condition triggered by exposure to traumatic events and characterized by persistent alterations in the neuroendocrine, immune, and central nervous systems. Recent evidence demonstrates that neuroinflammation plays a central role in the pathophysiology of PTSD, being driven by microglial activation, increased blood-brain barrier permeability, and the release of pro-inflammatory cytokines. These processes promote dysfunction of neurotransmitter systems, including serotonin, dopamine, glutamate, gamma-aminobutyric acid (GABA), and norepinephrine, impairing synaptic plasticity, memory consolidation, and stress response regulation. Consequently, symptoms such as hypervigilance, intrusive recollections, avoidance behaviors, mood disturbances, and cognitive deficits are maintained, contributing to the chronic course of the disorder. Final considerations: Understanding the neuroinflammatory mechanisms involved provides opportunities to develop strategies capable of modulating the inflammatory response and restoring neurochemical homeostasis, thereby promoting more effective therapeutic approaches.
References
ACOSTA SA, et al. Traumatic brain injury activates the adult hippocampal neurogenic niche and generates new neurons with altered morphology. Brain Injury. 2013; 27(7-8): 935-951.
AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR). 5th ed. Washington: American Psychiatric Association Publishing. 2022.
BARLATTANI F, et al. Gut microbiota, neuroinflammation and novel therapeutic strategies in post-traumatic stress disorder. Journal of Neuroinflammation. 2025; 22: 118.
BREMNER JD. Traumatic stress: effects on the brain. Dialogues in Clinical Neuroscience. 2006; 8(4): 445-461.
CHEN Y, et al. Advances in the pharmacological treatment of post-traumatic stress disorder: targeting neuroinflammation and oxidative stress. Frontiers in Pharmacology. 2021; 12: 712690.
DELL'OSTE V, et al. Peripheral inflammatory biomarkers in post-traumatic stress disorder: current evidence and future perspectives. Brain, Behavior, & Immunity – Health. 2023; 32: 100676.
DONG Y, et al. Microglial NLRP3 inflammasome contributes to fear memory impairment and anxiety-like behavior after traumatic stress. Brain, Behavior, and Immunity. 2020; 87: 273-287.
DOW JD, OBAID S. Neuroinflammation, oxidative stress, and blood-brain barrier dysfunction in post-traumatic stress disorder. Neuroscience & Biobehavioral Reviews. 2025; 168: 105962.
ENOMOTO M, et al. Involvement of microglia in disturbed fear memory regulation: Possible microglial contribution to the pathophysiology of posttraumatic stress disorder. Neurochemistry International. 2021; 142: 104921.
FONSECA R, et al. Neuroinflammation and microglial activation in post-traumatic stress disorder: an updated review. Brain, Behavior, & Immunity – Health. 2024; 37: 100772.
GOVINDULA A, et al. Emphasizing the Crosstalk Between Inflammatory and Neural Signaling in Post-traumatic Stress Disorder (PTSD). Journal of Neuroimmune Pharmacology. 2023; 18: 248-266.
HORI H, KIM Y. Inflammation and post-traumatic stress disorder. Psychiatry and Clinical Neurosciences. 2019; 73: 143-153.
KATRINLI S, et al. The role of the immune system in posttraumatic stress disorder. Translational Psychiatry. 2022; 12: 313.
LEE DH, et al. Neuroinflammation in post-traumatic stress disorder. Biomedicines. 2022; 10: 953.
LINDQVIST D, et al. Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress. Brain, Behavior, and Immunity. 2014; 42: 81-88.
LIU YD, et al. PET Imaging Unveils Neuroinflammatory Mechanisms in Psychiatric Disorders: From Microglial Activation to Therapeutic Innovation. Molecular Neurobiology. 2025; 62: 15318-15335.
PASSOS IC, et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. The Lancet Psychiatry. 2015; 2(11): 1002-1012.
PERUZZOLO TL, et al. Inflammatory and oxidative stress markers in post-traumatic stress disorder: a systematic review and meta-analysis. Molecular Psychiatry. 2022; 27: 3150-3163.
SAH A, SINGEWALD N. The (neuro)inflammatory system in anxiety disorders and PTSD: potential treatment targets. Pharmacology & Therapeutics. 2025; 269: 108825.
WANG Z, et al. Neuroinflammation and synaptic dysfunction in post-traumatic stress disorder. Journal of Psychiatric Research. 2021; 141: 262-271.
ZUO C, et al. Dissecting the causal association between inflammation and post-traumatic stress disorder: A bidirectional Mendelian randomization study. Journal of Affective Disorders. 2023; 333: 436-445.
